IV Tubing Sets And Accessories Market Size, Share & Trends Analysis Report By Product (Primary, Secondary, Extension, Accessories), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

IV Tubing Sets And Accessories Market Size, Share & Trends Analysis Report By Product (Primary, Secondary, Extension, Accessories), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030


IV Tubing Sets And Accessories Market Growth & Trends

The global IV tubing sets and accessories market size is expected to reach USD 1.65 billion by 2030, registering a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of cancer, favorable government initiatives related to IV tubing sets and accessories, and increasing risk of malnutrition across the globe are the key driving factors for the market.

Increasing prevalence of chronic conditions, such as cancer, is positively impacting the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of vital nutrients, which help in maintaining strength, energy, and hydration level in patients suffering from a disease. According to statistics published by WHO, around 8.2 million deaths occur every year due to cancer, accounting for 13.0% of the deaths worldwide. Moreover, cancer cases are estimated to increase by 70.0% over the next couple of decades. Increasing prevalence of cancer is one of the major drivers of IV tubing sets and accessories.

Cancer generally leads to a rise in the incidence of stomach ulcers, disturbance in the normal functioning of the GI tract, and development of physical obstructions, thereby resulting in an increased requirement for parenteral nutrition. In addition, a common symptom associated with cancer is anorexia or unintentional weight loss, requiring replenishment through the parenteral route of administration. Since IV tubing sets and accessories is one of the essential requirements for the parenteral nutrition, the demand is anticipated to surge in the coming years. These factors are anticipated to propel the IV tubing sets and accessories market growth over the forecast period.

Ambulatory surgery centers (ASC), also known as outpatient surgery centers, segment is anticipated to be the fastest growing segment over the forecast period. ASC are generally opted by patients undergoing less complicated procedures as minimally invasive interventional procedures allow rapid healing and require shorter hospital stay.

IV Tubing Sets And Accessories Market Report Highlights
  • The primary IV tubing sets segment led the market with the largest revenue share of 32.2% in 2024, due to their essential role in diverse medical procedures, continuous advancements in product design and materials, and cost-effectiveness.
  • Based on application, the peripheral intravenous catheter insertion segment led the market with the largest revenue share of 48.5% in 2024, due to its widespread use in various medical settings, advancements in catheter design and materials, and the increasing adoption of minimally invasive procedures.
  • Based on end-use, the hospitals segment led the market with the largest revenue share of 45.1% in 2024.
  • North America dominated the IV tubing sets and accessories market with a largest revenue share of 46.9% in 2024, driven by the high prevalence of chronic diseases, an aging population, technological advancements, the expansion of home healthcare services, and the impact of the COVID-19 pandemic.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Germany & Netherlands Medical Marijuana Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Germany & Netherlands Medical Marijuana Market: Product Type Business Analysis
4.1. Product Type Market Share, 2024 & 2030
4.2. Product Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
4.4. Flower
4.4.1. Flower Market, 2018 - 2030 (USD Million)
4.5. Oil
4.5.1. Oil Market, 2018 - 2030 (USD Million)
Chapter 5. Germany & Netherlands Medical Marijuana Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Pain
5.4.1. Chronic Pain Market, 2018 - 2030 (USD Million)
5.5. Mental Disorders
5.5.1. Mental Disorders Market, 2018 - 2030 (USD Million)
Chapter 6. Germany & Netherlands Medical Marijuana Market: Country Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2024 & 2030
6.2. Country Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. Germany
6.4.1. Germany Medical Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Key Country Dynamics
6.4.3. Regulatory Framework
6.4.4. Competitive Insights
6.5. Netherlands
6.5.1. Netherlands Medical Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Key Country Dynamics
6.5.3. Regulatory Framework
6.5.4. Competitive Insights
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. ADREXpharma GmbH
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Type Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Canopy Growth Corporation
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Type Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Aphria, Inc
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Type Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Aurora Cannabis
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Type Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Tilray
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Type Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. GW Pharmaceuticals, plc
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Type Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Organigram Holdings, Inc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Type Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. The Cronos Group
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Type Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Demecan GmbH
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Type Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Cannamedical Pharma GmbH
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Type Benchmarking
7.5.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings